Клензит

Quick links to important sections

Клензит

Selected form

Treatment option: Zits, Blackheads, Acne Vulgaris

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Клензит

Property Description
Active ingredient Adapalene
Form Gel
Pharmacological class Synthetic retinoid (Third-generation)
General purpose Topical anti-acne agent
Origin Synthetic (Naphthoic acid derivative)

Клензит is a single-component synthetic topical medication primarily used as a foundational intervention for acne, delivered in a gel form. Its core identity is defined by its sole active component, Adapalene, and its precise classification as a third-generation retinoid.


1. Клензит: Definition and Pharmacological Class

Клензит is a topical medication whose active ingredient, Adapalene, is a chemically stable naphthoic acid derivative. It is pharmacologically classified as a synthetic retinoid, specifically categorized as a retinoid for topical use. Adapalene is recognized for its unique chemical stability, which contributes to its performance in managing non-inflammatory and inflammatory acne lesions.

This medication’s designation as a third-generation retinoid means its structure is entirely synthetic, engineered for enhanced stability and targeted action. Adapalene functions as a highly specific Retinoic Acid Receptor (RAR) agonist, primarily targeting the RAR-beta and RAR-gamma nuclear receptors.


2. Composition, Form, and General Purpose

The medication is formulated as a non-greasy gel base, which serves as the vehicle for the topical application of Adapalene to the skin. The general purpose of Клензит is to act as a topical anti-acne agent by addressing the core pathological processes that cause lesions associated with Acne vulgaris.

The gel formulation supports the efficient delivery of Adapalene to the follicular units, where it functions as a keratolytic agent and a modulator of cellular differentiation. Adapalene acts by normalizing follicular keratinization and reducing microcomedone formation. This means the medicine helps to prevent the excessive buildup of dead cells and subsequent pore blockage, a key factor in acne development, offering a foundational method for clearing skin pores.

Regulatory References

  1. Adapalene (StatPearls, NIH)

What side effects are possible with Клензит?

Possible Side Effects and Safety Information

The safety profile for Adapalene, the active ingredient in Клензит, is established through clinical trials and postmarketing surveillance, as documented by governmental regulatory agencies.

Officially Documented Adverse Reactions

The most frequently reported adverse effects are primarily local cutaneous reactions occurring at the application site. Frequencies are based on official regulatory data:

  • Common (≥ 1%): Erythema (redness), Scaling, Dryness, Stinging/Burning sensation, Pruritus (itching), Skin Discomfort, and Desquamation (peeling).
  • Uncommon (≤ 1%): Acne flare, Contact dermatitis, Conjunctivitis, Eyelid edema, Skin discoloration, and Rash.

Serious Adverse Reactions

Rare but serious systemic reactions have been reported via postmarketing surveillance, typically categorized under Immune System Disorders. These include Anaphylaxis and Angioedema (swelling of tissues, which may affect the face or throat).


Safety Restrictions and Population-Specific Cautions

Time-Related Patterns: Local skin irritation is most likely during the first two to four weeks of treatment and typically lessens with continued use.

Regulatory Restrictions: The medication is contraindicated in individuals with known hypersensitivity to Adapalene. It must not be applied to skin that is compromised (e.g., cuts, abrasions, eczema, or sunburn). Exposure to UV light (sunlight and sunlamps) must be minimized.

Population Cautions: Adapalene is classified as Pregnancy Category C; use during pregnancy should be considered only if the potential benefit outweighs the risk. Safety has not been established for pediatric patients below the age of 12.

Overdose and Emergency Response

The official regulatory profile for Клензит (Adapalene Gel) overdose is classified into local cutaneous reactions and a theoretical systemic ingestion risk.

Documented Overdose Manifestations

Excessive topical application—using more product than directed—is documented to cause marked redness, peeling, and discomfort at the application site. Regulatory sources affirm that this excessive use will not result in faster or better therapeutic outcomes.

The medication is strictly for cutaneous use. A more severe hazard is associated with accidental or chronic oral ingestion of the gel, which may lead to systemic toxicity. This potential outcome is formally linked in regulatory documents to the side effects observed with excessive oral intake of Vitamin A (hypervitaminosis A syndrome).

When to Seek Urgent Medical Help

In the event of a suspected overdose, immediate emergency medical attention must be sought. If the product is accidentally swallowed, official guidance mandates immediately contacting a Poison Control Center or local emergency services, particularly if the individual has collapsed or is not breathing. Management of an overdose is defined as symptomatic and supportive, addressing the specific clinical manifestations that develop, as no specific antidote is officially documented. Furthermore, the official overdose sections do not contain explicit statements detailing population-specific (e.g., pediatric, renal, hepatic) overdose considerations.

Therapeutic Uses of Клензит

What Клензит Treats: Main Uses and Benefits

Клензит is generally used for the topical management of acne vulgaris, a condition involving recurrent or episodic manifestations of breakouts. The medication is applied across therapeutic domains where additional symptomatic support is needed, primarily focusing on skin clearing and inflammation control.

It is considered relevant for easing symptoms related to inflammatory or irritative states, such as redness and swelling. It is also used to help manage non-inflammatory symptoms like blackheads, whiteheads, and pimples. The medication is commonly used during phases of increased distress or discomfort when symptoms become more noticeable, offering a supportive relief that helps patients cope more steadily with these fluctuations.

This therapeutic area is relevant for managing symptoms that interfere with daily comfort. By assisting with maintaining the functional stability of the skin over time, it provides supportive relief that contributes to easing the overall symptom load.

Quick Fact: Relevant for Managing Visible Bumps and Inflammation

Regulatory References

  1. NIH MedlinePlus overview of Adapalene

Eligibility and Restrictions for Use

Who Can and Cannot Use Клензит?

Eligibility for using Клензит (Adapalene gel) is determined by official population guidelines established by regulatory authorities.


Populations Allowed and Restricted

Category Status (Official Regulatory Labeling)
Approved Age Group Patients 12 years of age and older
Use Not Established Children under 12 years of age; Geriatric patients (65+)
Breastfeeding Conditional Use; application to the chest area must be avoided
Specific Conditions Prohibited for use on skin that is sunburned, eczematous, cut, or abraded

Contraindications (Absolute Non-Eligibility)

The medication is strictly contraindicated for use in the following populations:

  • Pregnancy: Women who are currently pregnant or are actively planning a pregnancy.
  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to the active ingredient, adapalene, or any other components of the gel.

Use is restricted to patients 12 and over, and due to the strict prohibition in pregnancy, women of childbearing potential are often advised to use effective contraception throughout treatment. The official label specifies that use has not been established in older adults or in patients with renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Клензит (Adapalene) is a topical retinoid whose interaction profile is dominated by local pharmacodynamic effects due to minimal systemic absorption. Official regulatory labeling focuses primarily on preventing excessive skin irritation and photosensitivity.

Pharmacodynamic Interactions

Interaction Type Interacting Substances/Classes Constraint/Requirement
Additive Irritation Products with strong drying, abrasive, peeling, or astringent effects (e.g., sulfur, resorcinol, salicylic acid) Avoid concurrent use to mitigate the risk of severe skin irritation, redness, and dryness.
Additive Photosensitivity Products or medications known to cause phototoxicity or photosensitivity Minimize exposure to sunlight and artificial UV light during therapy, and avoid concurrent use of other photosensitizing agents.
Drug Class Redundancy Other topical retinoids (e.g., Tretinoin, Tazarotene) or other Adapalene-containing products Strictly avoid concurrent use to prevent excessive cumulative effects and potential overdose.

Pharmacokinetic and Systemic Considerations

Due to the negligible systemic absorption of Adapalene through the skin, no clinically significant interactions with medicines taken orally or injected (systemic drugs) are expected or documented in regulatory information, including those involving CYP450 enzymes or drug transporters.

Timing-Based Separation

Certain anti-acne products (such as topical benzoyl peroxide, clindamycin, or erythromycin) can be used concurrently, provided they are applied at separate times of the day (e.g., Adapalene at night and the other product in the morning) to reduce the risk of cumulative local irritation.

Mechanism of Action

How Клензит Works: A Dual Mechanism

Клензит (Klenzit) operates through two distinct, complementary mechanisms that influence cellular activity and microbial balance within the hair follicle. The retinoid component, Adapalene, acts as a selective agonist on gamma and beta Retinoic Acid Receptors (RARs) in the skin cell nucleus. This engagement modulates gene expression, leading to the normalization of follicular epithelial cell shedding, which reduces the potential for follicular occlusion. Adapalene also suppresses key inflammatory signaling cascades by interfering with transcription factors like AP-1. This action limits the production of pro-inflammatory mediators, contributing to the reduction of localized swelling and redness (edema and erythema).

Concurrently, the antibiotic component, Clindamycin, exerts an inhibitory effect on susceptible follicular bacteria (C. acnes). It works by binding to the 50S subunit of the bacterial ribosome, preventing the synthesis of proteins required for bacterial replication. This inhibition decreases the density of the bacterial population, altering the local microbial balance in the follicle.

Dosage and Administration Information

Administration Guidelines

This section outlines the instructions for the administration of Klenzit (adapalene gel, a retinoid).


Administration Scope

Feature Instruction
Route of Administration Cutaneous (Topical)
Dosing Schedule Apply a thin film of the gel once daily to the affected areas.
Timing/Frequency Once daily, preferably before bedtime (in the evening).
Preparation Requirements The skin area to be treated should be cleansed gently with a mild soap or soapless cleanser and patted dry before application.
Age-Group Rules Safety and effectiveness for patients under the age of 12 years have not been established.
Missed-Dose Rules If a dose is missed, skip the missed dose and continue with the regular schedule. Do not apply double the amount to compensate.

Procedural Structure

The gel is for external use only. The instructions define a specific application procedure:

  1. Gently cleanse and thoroughly dry the skin area where the application will occur.
  2. Apply a thin layer of the gel to the entire affected skin area, not just individual lesions.
  3. Perform the application once daily in the evening, typically before retiring.
  4. Avoid contact with the eyes, lips, angles of the nose, and any mucous membranes. If accidental contact occurs, flush immediately with water.

These guidelines establish a controlled protocol, setting a specific schedule and application technique to ensure consistent and targeted use of the medicine. This structure prevents misuse, such as over-application or contact with sensitive membranes, which is a key component of the use protocol.

Recent Clinical Evidence

Клензит (Adapalene) is a topical retinoid primarily used in the management of acne vulgaris. Recent clinical evidence continues to support the efficacy and favorable tolerability profile of adapalene, both as a monotherapy and, increasingly, in fixed-dose combination products.


Efficacy in Combination Therapy

Fixed-dose combinations of adapalene, such as the two-ingredient gel (Adapalene 0.1%/Benzoyl Peroxide 2.5%) and the newer triple-combination gel (Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1%), have demonstrated superior clinical outcomes in treating moderate-to-severe acne compared to their individual components or corresponding vehicle gels. Multiple phase 3 and long-term open-label studies confirm that these fixed combinations lead to:

  • Significant lesion reduction: Substantial decreases in both inflammatory and non-inflammatory lesions (comedones, papules, and pustules) are commonly observed as early as four weeks and continue to improve over 12 to 24 weeks.
  • High treatment success rate: A high percentage of patients achieve treatment success, defined as clear or almost clear skin with at least a two-grade reduction in overall severity score.
  • Improved long-term outcomes: Extended use over six months has shown continued efficacy and significant improvement in acne sequelae, including a reduction in post-inflammatory hyperpigmentation (PIH) and erythema (PIE), and, in some cases, modest improvements in scarring.

Tolerability and Safety

Adapalene is consistently noted for having a better skin tolerability profile than some earlier generation topical retinoids, contributing to better patient adherence. Common adverse events are transient and generally mild to moderate in severity, typically including localized skin reactions such as dryness, scaling, burning, and erythema. Clinical trials reinforce that these irritation symptoms often peak early in the treatment course and tend to decrease over time with continued use. For combination products that include an antibiotic like clindamycin, the addition of benzoyl peroxide has been shown to be effective in minimizing the risk of C. acnes antimicrobial resistance.

Frequently Asked Questions (FAQ)

Common questions about Клензит (FAQ)

Q: What is the main purpose of Клензит and how is it different from a regular pimple cream?

Official product information indicates that Клензит is a topical anti-acne agent containing Adapalene, a synthetic retinoid. This means its purpose is to influence cellular processes in the skin by normalizing cell shedding and helping to reduce the formation of pore blockages.

This mechanism of action, which involves targeting specific cell receptors, is what sets it apart from many non-retinoid topical agents.

Q: Is it normal for my acne to appear worse during the first few weeks of using Клензит?

Regulatory documents note that common local skin reactions, such as dryness, redness, and scaling, are most likely to occur during the initial two to four weeks of use.

While these irritative symptoms often decrease with continued use, an actual acne flare is listed in the official documentation as an uncommon side effect.

Q: What kind of moisturizers are generally compatible with Клензит to help with dryness?

Regulatory warnings focus on preventing severe skin irritation. Therefore, products that are abrasive, peeling, or strongly drying must be avoided during therapy.

Official guidelines recommend gently cleansing the skin before application, suggesting that compatible adjunctive skin products may benefit from being gentle and non-irritating.

Q: Can Клензит be used on the body, such as the back or chest, in addition to the face?

The administration guidelines state that the gel should be applied to the affected areas where acne lesions are present.

Official documentation does not typically restrict use to the face only, but rather to the areas requiring treatment.

Q: Why are some people advised to use Клензит only at night?

The product is generally applied in the evening because official warnings emphasize the need to minimize exposure to natural and artificial UV light during therapy.

This timing helps to reduce the risk of photosensitivity (increased sensitivity to the sun) associated with the medicine.

Q: Is it required to avoid all alcohol-containing products while using Клензит?

Official drug labeling advises against using products that have strong drying, abrasive, peeling, or astringent effects.

This is intended to mitigate the risk of severe skin irritation when combined with the medication. Many alcohol-containing topical products fall into the category of drying or astringent agents.

Q: Does missing an application of Клензит significantly impact the overall treatment results?

If an application is missed, the official procedure is to skip the missed dose and simply continue with the regular daily application schedule. The guidelines state not to apply double the amount.

The effectiveness of the treatment relies on consistent, long-term use as opposed to immediate, high application amounts.

Q: Can people who are exposed to high levels of sun due to their job or lifestyle still use Клензит?

According to the official warnings, exposure to UV light, including sunlight and sunlamps, must be minimized during the entire period of therapy.

The medicine is not intended for use in situations where unavoidable high sun exposure is a routine part of a person's life, as it could pose an increased risk of phototoxicity.

Q: Why is it important to apply a thin layer of Клензит and not use a larger amount?

Regulatory guidelines specify applying only a thin film of the gel.

Applying larger amounts is not shown to speed up the therapeutic effect. Using more than the recommended thin layer may, however, increase the severity of common local adverse reactions, such as irritation, redness, and excessive dryness.

Q: Can using Клензит help improve the overall texture of the skin?

Studies and official information indicate that the medication's effects, such as the normalization of cell shedding, can contribute to overall skin appearance. Evidence suggests it has been associated with a reduction in both post-inflammatory hyperpigmentation (PIH), which are common dark marks, and erythema (PIE) (red marks), and may offer modest improvements in acne scarring.

Q: Does the efficacy of Клензит change based on the severity of the acne (mild, moderate, or severe)?

The product is officially indicated for the topical treatment of acne vulgaris, which is the general medical classification covering a variety of acne lesion types.

Clinical studies have demonstrated the medicine's efficacy in treating a wide range of acne severity, showing substantial reductions in both inflammatory and non-inflammatory lesions.

Q: Can Клензит be used for acne that appears as deep, painful cysts or nodules?

The official indication for this medicine is the topical treatment of Acne vulgaris. This is the broad medical classification that includes various lesion types.

While its mechanism addresses both inflammatory and non-inflammatory lesions, the specific use for severe, deep lesions like cysts or nodules falls under the general scope of treatment for Acne vulgaris.

How should Клензит be stored and disposed of?

How to Store and Dispose of Klenzit (Adapalene Gel)

Official regulatory guidelines strictly define the storage and disposal requirements for Klenzit (Adapalene Gel 0.1%).

Storage Conditions

  • Temperature: Store at Controlled Room Temperature, which is typically 20 C to 25 C (68 F to 77 F). The gel must be protected from freezing.
  • Protection: Keep the container tightly closed and protect the gel from light and excess moisture.
  • Child Safety: It is mandatory to keep this medicine out of the sight and reach of children.

Disposal Requirements

  • Unused or expired Klenzit must be disposed of in accordance with local requirements.
  • The official label typically contains no special instructions beyond local waste regulations for general disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Клензит found in:

A-Z Index: